nationalpost.com
New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study
At two years, advanced prostate cancer patients taking the trial drug, in addition to their standard treatment, had a 52 per cent lower risk of cancer spread or death.